- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 43.86M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 44.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 43.8M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $2.63M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $2.63M |
| Capex | Q1 2026 · Mar 31, 2026 | $5.39M |
| Capex | Q1 2026 · Mar 31, 2025 | $4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$20M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $51.32M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $141.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $162.64M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $194.21M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $205.82M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $17.57M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $17.74M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $37.07M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $37.68M |
| Total Liabilities restated | Q1 2026 · Mar 31, 2025 | $39.21M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $84.14M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $108.6M |
| Current Assets restated | Q1 2026 · Mar 31, 2025 | $149.13M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $179M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $200.32M |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $233.42M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.41 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.41 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.15M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.88M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $840K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.39M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$20.58M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$18.09M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$20.84M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$19.46M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$15.86M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | −$15.19M |
| Revenue | Q1 2026 · Mar 31, 2026 | $31.95M |
| Revenue | Q1 2026 · Mar 31, 2025 | $17.54M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $32.19M |